Weight management with semaglutide leads to a sustained reduction in triptan prescriptions for patients requiring acute migraine relief therapies.

Few women initiate systemic hormone therapy for menopausal symptoms, and the majority of patients who do discontinue treatment within the first year.

HealthDay News — Menopausal hormone therapy (MHT) initiation in perimenopausal or recently postmenopausal women with vasomotor symptoms may reduce cardiovascular disease (CVD) risk, with more ...